Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  American Journal of Gastroenterology

• Publication date

  1994-06-22

• Fields of study

  Medicine

• Identifiers
  PMID 8017396
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Surgical therapy in Barrett's esophagus.

  2001cited by this paper
• Differences in manometry and 24-H ambulatory pH-metry between patients with and without endoscopic or histological esophagitis in gastroesophageal reflux disease.

  1993cited by this paper
• Circadian esophageal motor function in patients with gastroesophageal reflux disease.

  1990cited by this paper
• Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

  1987cited by this paper
• Barrett's esophagus: clinical, endoscopic, histologic, manometric, and electrical potential difference characteristics.

  1984cited by this paper
• Barrett's esophagus. Functional assessment, proposed pathogenesis, and surgical therapy.

  1983cited by this paper
• Barrett's esophagus. Clinical review of 26 cases.

  1978cited by this paper

• Chemoprevention in Barrett's Esophagus: An Updated Review.

  2025cites this paper
• The Discrepancy Between Subjective and Objective Clinical Endpoints in Gastroesophageal Reflux Disease

  2022cites this paper
• Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline

  2022cites this paper
• Current Status of Chemoprevention in Barrett's Esophagus.

  2021cites this paper
• Sound the Alarm for Barrett's Screening!

  2019cites this paper
• The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective

  2018cites this paper
• The Hibernating Bear—A Good Analogy to Explain Why Acute Fatty Liver of Pregnancy Manifests in Late Pregnancy

  2018cites this paper
• Effects of omeprazole or anti-reflux surgery on lower oesophageal sphincter characteristics and oesophageal acid exposure over 10 years

  2017cites this paper
• The Role of Acid Suppression in Barrett's Esophagus.

  2017cites this paper
• Response to TNF-α Is Increasing Along with the Progression in Barrett’s Esophagus

  2017cites this paper
• Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population‐based nested case‐control study

  2017cites this paper
• Who Deserves Endoscopic Screening for Esophageal Neoplasia?

  2017cites this paper
• Systematic review with meta‐analysis: prevalent vs. incident oesophageal adenocarcinoma and high‐grade dysplasia in Barrett's oesophagus

  2016cites this paper
• Prevalence and Predictors of Gastroesophageal Reflux Complications in Community Subjects

  2016cites this paper
• Gastroesophageal Reflux Disease

  2016cites this paper
• Effect of antireflux surgery for Barrett's esophagus: long-term results.

  2016cites this paper
• Medical management of Barrett's esophagus

  2015cites this paper
• Transoral Incisionless Fundoplication Effective in Eliminating GERD Symptoms in Partial Responders to Proton Pump Inhibitor Therapy at 6 Months

  2015cites this paper
• The Effect of Proton Pump Inhibitors on Barrett's Esophagus.

  2015cites this paper
• Unmet Needs in the Treatment of Gastroesophageal Reflux Disease

  2015cites this paper
• The patterns of reflux can affect regression of non-dysplastic and low-grade dysplastic Barrett’s esophagus after medical and surgical treatment: a prospective case–control study

  2015cites this paper
• Antireflux Surgery for Dysplastic Barrett

  2015cites this paper
• Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus.

  2015cites this paper
• Surgical Management of Barrett's Esophagus.

  2015cites this paper
• The Effects of Transoral Incisionless Fundoplication on Chronic GERD Patients: 12-Month Prospective Multicenter Experience

  2014cites this paper
• DUODENO-GASTROESOPHAGEAL REFLUX COMBINED AND ISOLATED

  2013cites this paper
• Three-Year Results of a Multicenter Prospective Study of Transoral Incisionless Fundoplication

  2013cites this paper
• Review Article; Duodeno-Gastro-Esophageal Reflux Combined and Isolated

  2013cites this paper
• Barrett's oesophagus: epidemiology, cancer risk and implications for management

  2013cites this paper
• The Dose of Omeprazole Required to Achieve Adequate Intraesophageal Acid Suppression in Patients with Gastroesophageal Junction Specialized Intestinal Metaplasia and Barrett’s Esophagus

  2013cites this paper
• Long-Term Follow-Up of Malignancy Biomarkers in Patients With Barrett's Esophagus Undergoing Medical or Surgical Treatment

  2012cites this paper
• Endoscopic ablative therapy for Barrett's esophagus: a potential cause of eosinophilic esophagitis.

  2012cites this paper
• Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation.

  2012cites this paper
• Diagnosis and management of Barrett's esophagus.

  2012cites this paper
• The Role of Proton Pump Inhibitors in Gastro-oesophageal Reflux Disease

  2012cites this paper
• Circulating DNA markers of gastro-intestinal cancers

  2012cites this paper
• A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication.

  2012cites this paper
• [Diagnosis of oesophageal reflux by PH, impedance, and bilirubin measurement: recommendations of the German Society of Neurogastroenterology and of the working group for neurogastroenterology of the German Society for Digestive and Metabolic Diseases].

  2012cites this paper
• Barrett’s Oesophagus

  2012cites this paper
• American Gastroenterological Association technical review on the management of Barrett's esophagus.

  2011cites this paper
• Prevalence of Esophageal Eosinophils in Patients With Barrett's Esophagus

  2011cites this paper
• Role of Acid Suppression in the Development and Progression of Dysplasia in Patients with Barrett’s Esophagus

  2011cites this paper
• Role of minimally invasive surgery in the modern treatment of Barrett's esophagus.

  2011cites this paper
• Importance of a multidisciplinary approach for the treatment of Barrett’s esophagus

  2011cites this paper
• Barrett's esophagus after laparoscopic Nissen-Rossetti fundoplication: functional evaluation.

  2011cites this paper
• Barrett's esophagus: surgical treatments

  2011influential citation
• Laparoscopic surgical treatment for patients with short- and long-segment Barrett's esophagus: which technique in which patient?

  2011cites this paper
• Gastroesophageal reflux disease: From heartburn to cancer.

  2010cites this paper
• Pathophysiology and treatment of Barrett's esophagus.

  2010cites this paper
• The influence of symptom type and duration on the fate of the metaplastic columnar‐lined Barrett’s oesophagus

  2009cites this paper
• Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus.

  2009cites this paper
• Barrett esophagus and esophageal adenocarcinoma

  2009cites this paper
• Medical or Surgical Management of GERD Patients with Barrett’s Esophagus: The LOTUS Trial 3-Year Experience

  2008cites this paper
• Proton pump inhibitors in Barrett's esophagus: Pluripotent but controversial

  2008cites this paper
• Barrett's esophagus in 2008: an update.

  2008cites this paper
• Review: Barrett's esophagus and the increasing role of endoluminal therapy

  2008cites this paper
• Esophageal Acid Exposure on Proton Pump Inhibitors in Unselected Asymptomatic Gastroesophageal Reflux Disease Patients

  2008cites this paper
• Relationship of Gastroesophageal Reflux Disease with Adenocarcinoma of the Distal Esophagus and Cardia

  2008cites this paper
• Time esophageal pH < 4 overestimates the prevalence of pathologic esophageal reflux in subjects with gastroesophageal reflux disease treated with proton pump inhibitors

  2008cites this paper
• Barrett's esophagus: pathogenesis, treatment, and prevention.

  2008cites this paper
• Microbial colonization of the upper gastrointestinal tract in patients with Barrett's esophagus.

  2007cites this paper
• ACG Practice Guidelines: Esophageal Reflux Testing

  2007cites this paper
• Barrett’s esophagus

  2007cites this paper
• Efficacy in intra-oesophageal acid suppression may decrease after 2-year continuous treatment with proton pump inhibitors.

  2007cites this paper
• GERD: New Strategies and New Failures

  2007cites this paper
• Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence

  2006cites this paper
• The impact of reflux composition on mucosal injury and esophageal function

  2006cites this paper
• Refractory Heartburn to Proton Pump Inhibitors: Epidemiology, Etiology and Management

  2006cites this paper
• [Endoscopic treatment of Barrett's oesophagus].

  2006cites this paper
• The importance of symptom assessment in the surgical treatment of gastroesophageal reflux disease and Barrett’s esophagus

  2006cites this paper
• Review article: intragastric and oesophageal pH monitoring in patients with gastro‐oesophageal reflux disease

  2006cites this paper
• Ambulatory pH Monitoring: New Advances and Indications.

  2006cites this paper
• Gastroesophageal reflux disease symptoms on antisecretory therapy: acid, non-acid, or no GERD.

  2006cites this paper
• Gastric and Esophageal pH in Patients With Barrett's Esophagus Treated With Three Esomeprazole Dosages: A Randomized, Double-Blind, Crossover Trial

  2006cites this paper
• Traitement endoscopique de l'endobrachyœsophage

  2006cites this paper
• Medical Management of GERD: Algorithms and Outcomes

  2006cites this paper
• Systematic review: proton‐pump inhibitor failure in gastro‐oesophageal reflux disease – where next?

  2005cites this paper
• Review article: putting immediate‐release proton‐pump inhibitors into clinical practice – improving nocturnal acid control and avoiding the possible complications of excessive acid exposure

  2005cites this paper
• Barrett’s oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?

  2005cites this paper
• Control of intra-oesophageal and intra-gastric pH with proton pump inhibitors in patients with Barrett's oesophagus.

  2005cites this paper
• Effect of lower esophageal sphincter distension and acidification on esophageal pressure and electromyographic activity: the identification of the "sphinctero-esophageal excitatory reflex".

  2005cites this paper
• Lack of predictors of normalization of oesophageal acid exposure in Barrett's oesophagus

  2005cites this paper
• Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility.

  2005cites this paper
• Histological inflammatory changes after surgery at the epithelium of the distal esophagus in patients with Barrett's esophagus: a comparison of two surgical procedures.

  2004cites this paper
• Barrett metaplasia: reassessment of treatment and follow-up

  2004cites this paper
• Oesophageal and gastric pH profiles in patients with gastro‐oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors

  2004cites this paper
• Laparoscopic treatment of Barrett's esophagus.

  2004cites this paper
• Persistent acid and bile reflux in asymptomatic patients with Barrett esophagus receiving proton pump inhibitor therapy.

  2004cites this paper
• Laparoscopic treatment of Barrett's esophagus*.

  2004cites this paper
• Gastrin-Induced Cyclooxygenase-2 Expression in Barrett’s Carcinogenesis

  2004cites this paper
• Review article: management of oesophageal adenocarcinoma — control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus

  2004cites this paper
• Surgery of Gastroesophageal Reflux Disease: A Competitive or Complementary Procedure?

  2004cites this paper
• Acid Suppression and Chemoprevention in Barrett’s Oesophagus

  2004cites this paper
• Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.

  2004cites this paper
• Acid Inhibition in GERD—How Much is Enough?

  2004cites this paper
• Gastroesophageal Reflux and Barrett’s Esophagus

  2004cites this paper
• How should Barrett’s ulceration be treated?

  2004influential citation
• Review article: Barrett's oesophagus and carcinoma in Japan

  2004cites this paper
• Complete Elimination of Reflux Symptoms Does not Guarantee Normalization of Intraesophageal and Intragastric pH in Patients with Gastroesophageal Reflux Disease (GERD)

  2004cites this paper
• Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.

  2004cites this paper